SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

An alleged early leak of Phase 3 results for Moderna and Mercks personalized melanoma vaccine combined with Keytruda triggered a sharp selloff, with traders debating whether the reported benefit fell short of expectations or whether the reaction was an overreaction to unverified information. The community is focused on the full clinical-data presentation and whether it will clarify the vaccines benefit.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is plunging alongside semiconductor and Nasdaq shares as traders cite oil and Iran-related uncertainty and worries about financing the AI buildout. The community is split between dip-buyers anticipating an oversold rebound and bearish traders warning that the semiconductor selloff could deepen; several also point to Lam Researchs supply and China-demand concerns.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias shares are selling off despite a quarterly earnings beat, with traders focused on negative free cash flow and a cut to the cash-conversion outlook, alongside higher restructuring costs and supply-chain pressures. Bulls call the reaction an overreaction given strong AI and cloud demand, while bears argue the results and call raised concerns about cash generation.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A large insider share unlock is widely cited by traders as adding selling pressure after SpaceXs post-earnings pop quickly reversed, with broader tech weakness and concerns about valuation and cash needs also weighing on the stock. The community is split between buyers treating the pullback as an opportunity and bears expecting further declines as newly eligible shares enter the market.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp, volatile selloff alongside memory and semiconductor stocks is driving discussion, with traders weighing AI-driven NAND demand and upcoming earnings against broader tech weakness, capex concerns, and Chinese competition. Some see positive AI-spending commentary and a potential earnings-driven rebound as support, while others expect more downside.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgents CFO departure and replacement by an internal finance executive have become the focus of a sharp selloff. Some traders speculate the exit could signal financial-reporting problems, while others see the reaction as excessive and point to the companys backlog and data-center power demand as reasons for confidence.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

A sharp selloff in Intel shares, alongside weakness across semiconductor and AI stocks, dominates the discussion as traders weigh broad market pressure and uncertainty ahead of earnings. The community is split between calling the decline an oversold buying opportunity and warning that the sector downturn or Intels own risks could mean further downside; claims of deliberate shorting remain speculation.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons rebound is being linked to Morgan Stanley naming it a top pick, alongside optimism about AWS growth and AI-related opportunities. Traders are cheering the upgrade but debating whether the gains can hold into the October 29 earnings report.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A broad Nasdaq selloff led by semiconductors has weighed on QQQ as traders debate concerns about AI spending and funding, alongside Iran-related oil and geopolitical risks. Sentiment is mostly bearish, with debate over whether the decline will deepen or offer a buying opportunity.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabets selloff ahead of its upcoming earnings report is driving discussion, with traders focused on whether AI competition threatens Search and whether heavy AI spending can deliver adequate returns. Bears fear weak Search results and guidance, while bulls see the decline as a buying opportunity and point to Cloud and AI growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key

The war on mental illness may be entering its most dramatic turning point in a generation. On April 18, President Trump signed an Executive Order directing the FDA to accelerate research and approval pathways for psychedelic therapies including psilocybin and ibogaine, calling them a potential lifeline for Americans suffering from debilitating conditions. Six days later, the FDA followed with formal priority review designations for qualifying psychedelic treatments, signaling that this once fringe sector of biotechnology has landed squarely in the mainstream of U.S. drug policy.Shares of ...

XTLB Stock Surges 90%, Breaches 200-DMA For First Time In Over 3 Months – Here’s What The Acquisition Of Psyga Bio Brings To The Table

Equity

XTL Biopharmaceuticals announced the acquisition of Psyga Bio to gain a major foothold in the psychedelic therapeutics industry.

Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets

The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine.  $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN

XAIR Stock More Than Doubled Today — What’s Driving The Rally?

Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.


CommScope Stock Rockets 91% As Retail Bulls Cheer $10.5B Asset Sale: ‘Get In While It’s Cheap!’

Once the sale is completed and all financial obligations are settled, CommScope intends to return surplus funds to investors. 

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

X.T.L. Biopharmaceuticals Ltd. - ADR

Neutral Sentiment

<ul class="summary-bullets"><li>Psyga Bio has seven approved Phase 2 clinical trials across areas such as mental health, addiction, and neurological disorders.</li><li>The deal also includes a licensed manufacturing facility capable of producing pharmaceutical-grade psychedelic compounds.</li><li>The deal comes days after the U.S. expedited the research and treatment using psychedelic therapies.</li></ul>Shares of XTL Biopharmaceuticals (XTLB) surged more than 90% on Wednesday, breaching the 200-day moving average for the first time in more than three months, after the biotech firm signaled a major move into the fast-growing psychedelic medicine industry by announcing the acquisition of Psyga Bio.<a href="https://stocktwits.com/symbol/XTLB">XTLB shares</a> recorded their biggest single-day jump since Dec. 26, 2026.<h2 class="st-heading-2">Expansion Into Psychedelic Therapeutics</h2>The acquisition will give XTL full ownership of Psyga, a company focused on developing treatments derived from psychedelic compounds like Psilocybin and Ibogaine. Psyga brings a strong pipeline, including seven approved Phase 2 clinical trials that are expected to begin patient enrollment soon across areas such as mental health, addiction, and neurological disorders.The deal also includes a licensed manufacturing facility capable of producing pharmaceutical-grade psychedelic compounds.Under the agreement, Psyga shareholders will receive equity representing 40% of XTL, with additional shares tied to key clinical and commercial milestones. No upfront cash payment will be made, the company said. Following the deal, Psyga will operate as a wholly owned subsidiary of XTL.<h2 class="st-heading-2">Regulatory Tailwinds Boost Sector</h2>The deal comes as regulatory support for psychedelic therapies is gaining momentum in the U.S. On April 18, 2026, President Donald Trump signed an order directing the U.S. Food and Drug Administration (FDA) to expedite research, approvals, and access to treatments such as Psilocybin and Ibogaine.Soon after, the FDA <a href="https://stocktwits.com/news-articles/markets/equity/fda-fast-tracks-psychedelic-research-trump-executive-order-cmps-help-stocks/cZBh5Y9Rec3">introduced</a> faster review pathways and priority actions for these therapies, improving the sector's outlook. The agency said this move will help expand the use of psychedelic-based medicines for conditions such as PTSD, treatment-resistant depression, and major depressive disorder.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘extremely high’ message volumes.One user highlighted a flag pattern on the charts and added that if the stock breaks above $4.30, a major upside is on the cards.<stembedurl>https://stocktwits.com/profitcatcher/message/651757764</stembedurl>The stock has gained around 34% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

XTL Biopharmaceuticals Ltd.

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$1.88
Prev Close	$1.87
Open	$1.86
Dividend Yield	0.00%
50-Day Moving Average	$2.37
Beta	0.62
Avg. Volume	5,274.11
PE Ratio	-4.18

52-Week High	$5.64
52-Week Low	$1.86
Market Capitalization	$7.94M
EPS (Annual)	-$0.3427
Price to Book	0.76
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

XTLB Fundamentals